CALL FOR PAPERS
Drug Delivery Call for Papers
Submit to PLOS ONE to get your research on cities in front of a global, interdisciplinary audience. Due to COVID-19 restrictions, PLOS ONE is extending the deadline for submissions to the Drug Delivery collection. This unique opportunity will allow authors to submit their research until February 19, 2021, including after the official collection launch in January 2021.
The efficacy and safety of a drug is highly impacted not only by how it is designed, but also by how and where it is delivered. In recent years there has been significant progress in the formulation of different drug delivery systems to improve the release and pharmacological profile of therapeutic drugs, reduce side effects, and enhance targeting to specific tissues and cell types.
In this Call for Papers, we welcome submissions that report on the various properties of drug delivery systems, including drug formulations and pro-drug approaches, synthesis of nanoparticle and exosome carriers, vaccine delivery, gene delivery, and co-delivery systems. The Call will also encompass in vitro and in vivo studies that focus on how the routes of drug administration impact drug delivery systems, drug bioavailability, toxicity, and pharmacokinetic and pharmacodynamic drug profiles. We welcome submissions that deal with computational studies of drug delivery systems or consider aspects of reproducibility in this complex interdisciplinary field. Submissions that focus on the clinical applications of delivery systems, including tumour targeting and infectious diseases are also highly encouraged.
PLOS ONE publishes primary research across all areas of science, including interdisciplinary research. Research articles are selected for scientific rigor rather than perceived impact.
Email questions to ONEcalls@plos.org